XIG (FHIR Server FHIR Server Version n/a)

FHIR IG Statistics (3234 ms)

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | au | be | BNW | br | ca | ch | cl | cr | cz | de | dk | ee | efss | essilux | eu | examples | fi | fr | il | in | it | jp | nl | no | nume | nz | pt | rdsuwearme | sami | se | sl | stt | test | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Realm US, Authority Hl7

16260 resources

By Version

R2: 52
R2B: 0
R3: 522
R4: 15248
R4B: 0
R5: 438
R6: 0

Package	Version	Identity	Name/Title	Status	Date
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.82	Cerumen Impaction	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.188	Radiotherapy	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.189	Radiotherapy	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.190	Radiotherapy	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.191	Head and Neck Anatomic Locations	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.192	Conditions Associated with Head and Neck Radiotherapy	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.193	Conditions Associated with Head and Neck Radiotherapy	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.194	Ear Canal Stenosis	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.195	Ear Canal Stenosis	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.196	Ear Canal Stenosis	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.197	Exostoses	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.198	Exostoses	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.199	Exostoses	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.200	Non intact Tympanic Membrane	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.201	Non Intact Tympanic Membrane	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.202	Non Intact Tympanic Membrane	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.246	Hearing Aids	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.250	DO NOT USE	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.251	Cerumenolytics	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.252	Irrigation	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.253	Irrigation	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31593.1.12.1.999.288	Otoscopy performed on exam	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31663.1.1.999.291	Otolaryngologist as a Clinician or Service	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.8.31102.1.1.999.123	Cerumen Impaction	active	2017-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31104.1.1.999.275	Dermatologic Diseases of the Ear	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31108.1.1.999.20	Keratoses Obturans	active	2017-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.221	Tympanoplasty	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.222	Tympanoplasty	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.223	Myringoplasty	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.224	Myringoplasty	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.225	Mastoidectomy	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.229	Mastoidectomy	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.227	Ear Surgery, Other	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.228	Ear Surgery, Other	active	2018-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.334	Sleep Apnea	active	2018-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.335	Sleep Apnea	active	2018-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.336	Sleep Apnea	active	2018-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.237	Allergic Rhinitis	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.238	Allergic Rhinitis	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.239	Allergic Rhinitis	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.263	Uncontrolled or severe asthma	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.264	Uncontrolled or severe asthma	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.265	Uncontrolled or severe asthma	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.300	Rhinosinusitis	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.301	Rhinosinusitis	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.302	Rhinosinusitis	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.303	Nasal Polyposis	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.304	Nasal Polyposis	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.305	Nasal Polyposis	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.306	Suspected Nasal Neoplasm	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.307	Suspected Nasal Neoplasm	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.308	Suspected Nasal Neoplasm	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.14.1.999.309	Other sinus conditions potentially requiring imaging	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.14.1.999.310	Other sinus conditions potentially requiring imaging	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.11.1.999.319	Intranasal Antihistamines	active	2017-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.12.1.999.320	Mast Cell Stabilizers	active	2017-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.13.1.999.321	Ophthalmic Antihistamines	active	2017-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.215	Sneezing as a finding	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.216	Sneezing as a Clinical Condition	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.217	Pruritus Unspecified or Other Location	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.218	Pruritus Unspecified or Other Location	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.11.1.999.272	Specific IgE Testing for Allergies	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.12.1.999.273	Immunoglobulin G Testing	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.13.1.999.274	Total IgE Testing	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34920.1.1.999.290	Clinicians who perform allergy testing	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35043.1.1.999.279	Radiography of face, head or neck	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.11.1.999.315	Intranasal Corticosteroids	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.316	Eustachian Tube Dysfunction	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.317	Eustachian Tube Dysfunction	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.318	Eustachian Tube Dysfunction	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35292.1.1.999.287	Oral Second Generation and Less Sedating Antihistamines	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35464.1.1.999.266	Leukotriene antagonist	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.11.1.999.267	Immunotherapy that is not Identified as Subcutaneous	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.14.1.999.268	Immunotherapy	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.12.37641.1.1.999.653	Fidaxomicin	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.12.37696.1.1.999.654	Proton Pump Inhibitors not including for H. pylori treatment	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.655	Clostridium difficile infection	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.656	Clostridium difficile infection	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.657	Clostridium difficile infection	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38167.1.1.999.594	Complete Blood Count (with Diff)	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38256.1.1.999.662	Metronidazole Systemic	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38266.1.1.999.663	Vancomycin non injectable	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38343.1.1.999.665	Creatinine	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.722	Ileus due to infection	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.723	Ileus due to infection	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.724	Ileus due to infection	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.725	Vomiting potentially due to CDI	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.726	Vomiting potentially due to CDI	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.727	Vomiting potentially due to CDI	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.728	Toxic Megacolon in adults	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.729	Toxic Megacolon in adults	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.730	Toxic Megacolon in adults	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.731	Abdominal Distension	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.732	Abdominal Distension	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.688	Septic Shock due to C. Diff	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.689	Septic Shock due to C. Diff	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.690	Septic Shock due to C. Diff	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.658	Antiperistaltic agents to avoid in C. diff	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.734	Systemic Antimicrobial Medications not used for CDI	active	2019-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37937.1.11.1.999.659	Recurrent Clostridium difficile infection	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37937.1.13.2.999.660	History of CDI	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38112.1.1.999.661	Consult Infectious Disease	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38827.1.1.999.691	Abdominal Xrays for CDI	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38839.1.1.999.692	CT of abdomen with contrast for fulminant CDI	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38904.1.1.999.693	Surgical consult for CDI	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.39406.1.1.999.694	Fecal microbiota transplantation	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.4.37623.1.1.999.645	Hospitalist	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.697	Positive result indicator	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.698	Clostridium Difficile Test	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.646	Body Temperature	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.647	Body Temperature	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.648	Diarrhea Potentially due to CDI	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.649	Diarrhea Potentially due to CDI	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.650	Diarrhea Potentially due to CDI	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.13.1.999.651	Leukocyte count	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.9.37637.1.1.999.652	Inpatient Setting	active	2019-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1	ONC Administrative Sex	active	2015-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.1	Substance Reactant for Intolerance	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.2	Clinical Substance	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.4	Medication Clinical Drug	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.5	Medication Clinical Brand specific Drug	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.6	CVX Vaccines Administered Vaccine Set	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.7	Clinical Drug Ingredient	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.8	Vaccine Clinical Drug	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.9	Substance Other Than Clinical Drug	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1018.240	SNOMED CT CORE Problem List	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1018.98	Route of Administration	active	2019-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.101	Gender Identity USCDI core	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.102	Unknown or did not answer	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.103	Other or unknown or refused to answer	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.12	Low Molecular Weight Heparin for VTE prophylaxis ingredient specific	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.120	Patient Sex for Quality Measurement	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.121	Federal Administrative Sex	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.14	Published test VS	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.24	Birth Sex	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.30	AdministrationUnitDoseForm	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.33	Sexual Orientation	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.40	MDP Test Intensional	active	2019-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.41	MDP Test HL7 Intensional	active	2019-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.46	Device Magnetic resonance (MR) Safety	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.47	Device Latex Safety	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.48	Implantable Device Status	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.56	Medical Reason Not Done SCT	active	2019-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.119	Phototherapy	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.120	Phototherapy	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.121	Phototherapy	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.122	Neonatal Jaundice	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.123	Neonatal Jaundice	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.124	Neonatal Jaundice	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.125	Maternal Drug Use	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.126	Maternal Drug Use	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.127	Maternal Drug Use	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.128	Fetal Conditions	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.129	Fetal Conditions	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.130	Fetal Conditions	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.131	Congenital Malformations	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.132	Congenital Malformations	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.133	Congenital Malformations	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.134	Social Indications	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.135	Social Indications	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.136	Social Indications	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.137	Neonatal Severe Birth Trauma	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.138	Neonatal Severe Birth Trauma	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.139	Neonatal Severe Birth Trauma	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.140	Neonatal Severe Hypoxia or Asphyxia	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.141	Neonatal Severe Hypoxia or Asphyxia	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.142	Neonatal Severe Hypoxia or Asphyxia	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.143	Neonatal Severe Shock and Resuscitation	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.144	Neonatal Severe Shock and Resuscitation	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.145	Neonatal Severe Shock and Resuscitation	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.146	Neonatal Severe Respiratory Complications	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.147	Neonatal Severe Respiratory Complications	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.148	Neonatal Severe Respiratory Complications	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.149	Neonatal Severe Infection	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.150	Neonatal Severe Infection	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.151	Neonatal Severe Infection	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.152	Neonatal Severe Neurological Complications	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.153	Neonatal Severe Neurological Complications	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.154	Neonatal Severe Neurological Complications	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.155	Neonatal Severe Shock and Resuscitation Procedures	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.156	Neonatal Severe Shock and Resuscitation Procedures	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.157	Neonatal Severe Shock and Resuscitation Procedures	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.158	Neonatal Severe Respiratory Procedures	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.159	Neonatal Severe Respiratory Procedures	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.160	Neonatal Severe Respiratory Procedures	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.161	Neonatal Severe Neurological Procedures	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.162	Neonatal Severe Neurological Procedures	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.163	Neonatal Severe Neurological Procedures	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.164	Neonatal Severe Septicemia	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.165	Neonatal Severe Septicemia	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.166	Neonatal Severe Septicemia	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.167	Neonatal Moderate Birth Trauma	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.168	Neonatal Moderate Birth Trauma	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.169	Neonatal Moderate Birth Trauma	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.170	Neonatal Moderate Respiratory Complications	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.171	Neonatal Moderate Respiratory Complications	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.172	Neonatal Moderate Respiratory Complications	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.173	Neonatal Moderate Respiratory Complications Procedures	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.174	Neonatal Moderate Respiratory Complications Procedures	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.175	Neonatal Moderate Respiratory Complications Procedures	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.176	Neonatal Moderate Birth Trauma with LOS	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.177	Neonatal Moderate Birth Trauma with LOS	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.178	Neonatal Moderate Birth Trauma with LOS	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.179	Neonatal Moderate Respiratory Complications with LOS	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.180	Neonatal Moderate Respiratory Complications with LOS	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.181	Neonatal Moderate Respiratory Complications with LOS	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.182	Moderate Neurological Complications with LOS Procedures	active	2019-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.183	Neonatal Moderate Neurological Complications with LOS Procedures	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.184	Neonatal Moderate Neurological Complications with LOS Procedures	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.185	Neonatal Moderate Respiratory complications with LOS Procedures	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.186	Neonatal Moderate Respiratory complications with LOS Procedures	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.187	Neonatal Moderate Respiratory complications with LOS Procedures	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.188	Single Liveborn Newborn Vaginal	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.189	Single Liveborn Newborn Vaginal	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.190	Single Liveborn Newborn Vaginal	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.191	Single Liveborn Newborn Cesarean	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.192	Single Liveborn Newborn Cesarean	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.193	Single Liveborn Newborn Cesarean	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.194	Birth Weight	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.195	Neonatal Moderate Infection with LOS	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.196	Neonatal Moderate Infection with LOS	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.197	Neonatal Moderate Infection with LOS	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.203	Neonatal Intensive Care Unit	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.204	Intensive Care Unit	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.205	Neonatal Intensive Care Unit	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.206	Intensive Care Unit	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.208	Blood Transfusion Administration	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.209	Blood Transfusion Administration	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.213	Blood Transfusion	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.214	Acute Respiratory Distress Syndrome	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.217	Amniotic Fluid Embolism	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.219	Aortic Aneurysm	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.220	Aortic Aneurysm	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.221	Cardiac Arrest Ventricular Fibrillation	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.223	Disseminated Intravascular Coagulation	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.225	Eclampsia	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.227	Heart Failure Cardiac Arrest Related to Procedure or Surgery	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.228	Heart Failure Cardiac Arrest Related to Procedure or Surgery	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.229	Puerperal Cerebrovascular Disorder	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.231	Pulmonary Edema	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.233	Acute Heart Failure	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.235	Severe Anesthesia Complications	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.237	Sepsis	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.239	Shock	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.24	Blood Transfusion Administration	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.241	Sickle Cell Disease with Crisis	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.243	Air and Thrombotic Embolism	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.245	Blood Transfusion	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.246	Blood Transfusion	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.247	Conversion of Cardiac Rhythm	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.248	Conversion of Cardiac Rhythm	active	2021-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.249	Hysterectomy	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.250	Hysterectomy	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.251	Tracheostomy	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.252	Tracheostomy	active	2021-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.253	Ventilation	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.254	Ventilation	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.255	Severe Maternal Morbidity Diagnoses	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.256	Severe Maternal Morbidity Procedures	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.267	Gestational Diabetes	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.269	Gestational Diabetes	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.271	HIV in Pregnancy Childbirth and Puerperium	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.272	HIV in Pregnancy Childbirth and Puerperium	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.274	Preexisting Diabetes	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.275	Preexisting Diabetes	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.277	Previous Cesarean	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.278	Previous Cesarean	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.279	Pulmonary Hypertension	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.281	Pulmonary Hypertension	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.282	Multiple Pregnancy	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.284	Multiple Pregnancy	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.286	Bleeding Disorder	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.287	Bleeding Disorder	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.289	Morbid or Severe Obesity	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.290	Morbid or Severe Obesity	active	2022-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.291	Economic Housing Instability	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.292	Economic Housing Instability	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.295	Thyrotoxicosis	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.296	Thyrotoxicosis	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.297	Preterm Birth	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.299	Preterm Birth	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.300	Placenta Accreta	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.302	Placenta Accreta	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.303	Placental Abruption	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.305	Placental Abruption	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.306	Neuromuscular Disease	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.308	Neuromuscular Disease	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.309	Autoimmune Disease	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.311	Autoimmune Disease	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.312	Mental Health Disorder	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.314	Mental Health Disorder	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.315	Bariatric Surgery	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.317	Bariatric Surgery	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.318	Substance Abuse	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.320	Substance Abuse	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.321	Anemia	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.323	Anemia	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.324	Severe Preeclampsia	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.326	Mild or Moderate Preeclampsia	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.327	Severe Preeclampsia	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.329	Mild or Moderate Preeclampsia	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.330	Hypertension	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.332	Hypertension	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.333	Renal Disease	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.335	Renal Disease	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.336	Gastrointestinal Disease	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.338	Gastrointestinal Disease	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.339	Cardiac Disease	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.341	Cardiac Disease	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.344	Aortic Aneurysm	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.357	Conversion of Cardiac Rhythm	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.358	Hysterectomy	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.359	Tracheostomy	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.360	Ventilation	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.361	Venous Thromboembolism in Pregnancy	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.363	Venous Thromboembolism in Pregnancy	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.364	Long Term Anticoagulant Use	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.366	Long Term Anticoagulant Use	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.368	Preadmission Observation Undelivered Mother	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.369	ED Visit and OB Triage	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.370	Present on Admission is No or Unable To Determine	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.371	COVID 19 Confirmed	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.372	COVID 19 Confirmed	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.373	COVID 19 Confirmed	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.374	Respiratory Conditions Related to COVID 19	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.375	Respiratory Conditions Related to COVID 19	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.376	Respiratory Conditions Related to COVID 19	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.377	Respiratory Support Procedures	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.378	Respiratory Support Procedures	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.379	Respiratory Support Procedures Related to COVID 19	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.387	Placenta Increta or Percreta	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.388	Placenta Increta or Percreta	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.67	Other Health Care Facility	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.10	Non essential Hypertension SNOMEDCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.102	Suicide Attempt	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.11	Cirrhosis ICD9CM	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.12	Cirrhosis ICD10CM	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.13	Cirrhosis SNOMEDCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.14	Cirrhosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.151	Polycystic Ovary Syndrome	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.16	Low Intensity Statin Therapy/Branded	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.17	Moderate Intensity Statin Therapy/Branded	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.18	High Intensity Statin Therapy/Branded	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.21	ALT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.230	Gestational Diabetes SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.231	Gestational Diabetes ICD10CM	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.233	All Results of High Risk HPV Test	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.234	High Risk HPV Positive Results	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.248	Suicide Attempt SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.26	Nonopioid pain medications	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.263	High Risk Positive HPV Results Without HPV16 or HPV18	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.264	CDS Pregnancy	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.265	CDS Pregnancy Intensional	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.266	Rhabdomyolysis Intensional	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.267	CDS Rhabdomyolysis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.268	HPV Negative Results	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.27	Non pharmacologic treatments for chronic pain ICD10PCS	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.28	Urine drug screen for pain management	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.29	Non pharmacologic treatments for chronic pain SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.292	Non pharmacologic treatments for chronic pain NCI	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.296	SCT Findings 202209	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.298	Cervical Cytology Test	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.299	HPV 16 Tests	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.300	HPV 18 Tests	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.302	Test Cervical Excision Procedures	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.303	Statin Combinations	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.305	Counseling for Physical Activity CPT	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.306	Counseling for Physical Activity ICD10CM	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.307	Counseling for Physical Activity CDS	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.308	Cardiovascular disease 10Y risk	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.309	SCT Findings 202309	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.311	SCT Procedures 202209	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.312	SCT Procedures 202309	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.313	Statin Allergen Grouping	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.319	Steward Transfer Test	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.320	Opioids ATCPROD N02A	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.322	Test 123	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.34	Opioid pain medications	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.36	Non pharmacologic treatments for chronic pain	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.40	Suicide attempt	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.42	Naloxone and Nalmefene medications	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.43	Benzodiazepine medications	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.44	Stool softeners and laxatives	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.47	Anxiety	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.48	Anxiety	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.50	Sleep disordered breathing	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.51	Sleep disordered breathing	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.52	Anxiety	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.53	Sleep disordered breathing	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.54	Adjuvant pain medications	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.55	Risk assessments relevant to pain management	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.6	Non essential Hypertension ICD9CM	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.7	Non essential Hypertension ICD10CM	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.79	Behavioral Counseling for Nutrition and Activity Referral	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.85	Impaired Glucose Tolerance	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.87	Fasting Plasma Glucose	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.88	Waist Circumference	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.9	Hypertension	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.90	Gestational Diabetes	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.92	First Degree Family Member	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.94	Glucose Tolerance Test Results	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.96	Dependence on dialysis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.99	Gestational Diabetes	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.460	Cluster Headache (ICD10CM)	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.461	Cluster Headache (ICD9CM)	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.464	Cluster Headache	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.467	Medication Therapy for Cluster Headache (RXNORM)	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.555	Patient Declines Treatment for Cluster Headache (SNOMEDCT)	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.558	Acute Cluster Headache Medication (RXNORM)	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.559	Long Term Preventive Medication for Cluster Headache	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.561	Oral Steroid for Cluster Headache	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.569	Migraine Preventive Medication	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.601	Acute Migraine Attack Medication	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.605	NSAID OTC Migraine Attack Medication	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.606	NSAID Prescribable Migraine Attack Medication	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.640	Neurologic Disorders	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.641	Neuromodulation for migraine	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.642	No pain with headache	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.643	Antiplatelets	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.644	Anticoagulants	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.645	Statin Medications	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.646	Anxiety Disorders (ICD10 and SNOMED)	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.648	Depression Diagnosis (ICD10 and SNOMED)	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.649	Psychosis (ICD10 and SNOMED)	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.650	Cluster Headache (SNOMED)	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.651	Galcanezumab (RxNorm)	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.652	Lithium (RxNorm)	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.653	Verapamil	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.654	Long term preventive medications for cluster headache	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.655	Short term preventive medication for cluster headache	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.656	Zolmitriptan	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.657	Sumatriptan	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.658	Dihydroergotamine	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.659	Acute cluster headache medication	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.660	Acute cluster headache treatment	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.661	Short term preventive treatment for cluster headache	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.662	Long term preventive treatment for cluster headache	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.663	Migraine diagnosis (ICD)	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.664	Prescribable NSAIDs and Acute Migraine Attack Medication	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.103	Abnormal Presentation	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.105	Abnormal Presentation	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.114	Hematocrit Lab Test	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.117	Potassium Lab Test	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.119	Sodium Lab Test	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.127	Platelet Count Lab Test	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.129	White Blood Cells Count Lab Test	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.130	Respiratory Rate	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.134	Glucose Lab Test	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.139	Bicarbonate Lab Test	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.15	Intravenous Thrombolytic tPA Therapy	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.151	Oxygen Saturation by Pulse Oximetry	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.152	Body Temperature	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.159	Body Weight	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.16	Intraarterial Thrombolytic tPA Therapy	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.163	Systolic Blood Pressure	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.171	Abnormal Presentation	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.173	Delivery of Singleton	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.21	Intravenous or Intraarterial Thrombolytic tPA Therapy	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.26	Estimated Gestational Age at Delivery	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.27	Cornual Ectopic Pregnancy	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.38	General Or Neuraxial Anesthesia	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.39	Low Dose Unfractionated Heparin for VTE Prophylaxis	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.41	Glycoprotein IIb IIIa Inhibitors	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.55	Oxytocin	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.56	Dinoprostone	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.58	Delivery Procedures	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.59	Delivery Procedures	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.66	PCI	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.67	PCI	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.68	Endotracheal Intubation	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.69	Endotracheal Intubation	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.98	Delivery of Singleton	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.99	Delivery of Singleton	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.225	Opioid Medication Assisted Treatment (MAT) SNOMED	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.241	Schedule II, III and IV Opioid Medications	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.242	Opioid Use Disorder	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.243	Opioid Use Disorder	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.265	Inpatient, Emergency, and Observation Locations	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.269	Medications for Opioid Use Disorder (MOUD)	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.274	NHSN Inpatient Encounter Class Codes	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.277	Emergency Department Location	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.278	Emergency Department Treatment Location	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.279	Triage	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.283	Emergency Department Location	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.284	Emergency Department Location	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.285	Mental Health Diagnosis without Substance Use Disorders	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.286	Decision to Transfer	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.35	Healthcare Agent or Proxy Choices	active	2022-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.10	Breastfeeding	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.100	Familial Hypercholesterolemia	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.102	Rhabdomyolysis	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.107	Low Intensity Statin Therapy	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.12	Liver Disease	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.13	Rhabdomyolysis	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.19	Atherosclerosis and Peripheral Arterial Disease	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.20	Atherosclerosis and Peripheral Arterial Disease	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.21	Atherosclerosis and Peripheral Arterial Disease	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.22	Liver Disease ICD9	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.37	Stable and Unstable Angina	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.39	Cerebrovascular Disease Stroke or TIA	active	2023-02

XIG built as of 20 Jun 2025. Found 77285 resources in 1238 packages.